The Anticonvulsant Ethosuximide Disrupts Sensory Function to Extend C. elegans Lifespan

Abstract

Ethosuximide is a medication used to treat seizure disorders in humans, and we previously demonstrated that ethosuximide can delay age-related changes and extend the lifespan of the nematode Caenorhabditis elegans. The mechanism of action of ethosuximide in lifespan extension is unknown, and elucidating how ethosuximide functions is important for defining endogenous processes that influence lifespan and for exploring the potential of ethosuximide as a therapeutic for age-related diseases. To identify genes that mediate the activity of ethosuximide, we conducted a genetic screen and identified mutations in two genes, che-3 and osm-3, that cause resistance to ethosuximide-mediated toxicity. Mutations in che-3 and osm-3 cause defects in overlapping sets of chemosensory neurons, resulting in defective chemosensation and an extended lifespan. These findings suggest that ethosuximide extends lifespan by inhibiting the function of specific chemosensory neurons. This model is supported by the observation that ethosuximide-treated animals displayed numerous phenotypic similarities with mutants that have chemosensory defects, indicating that ethosuximide inhibits chemosensory function. Furthermore, ethosuximide extends lifespan by inhibiting chemosensation, since the long-lived osm-3 mutants were resistant to the lifespan extension caused by ethosuximide. These studies demonstrate a novel mechanism of action for a lifespan-extending drug and indicate that sensory perception has a critical role in controlling lifespan. Sensory perception also influences the lifespan of Drosophila, suggesting that sensory perception has an evolutionarily conserved role in lifespan control. These studies highlight the potential of ethosuximide and related drugs that modulate sensory perception to extend lifespan in diverse animals.

Age‐related degeneration of the egg‐laying system promotes matricidal hatching in Caenorhabditis elegans

“…On days 4 and 6, surviving hermaphrodites were transferred to fresh dishes away from their progeny. On days 3, 5, and 7, egg-laying in response to serotonin was determined as previously described (Collins et al 2008a). …”

Does antiepileptogenesis affects sleep in genetic epileptic rats?

“…However, it is not likely that this acute mode of action of ETX can fully explain the beyond the treatment lasting antiepileptogenic and anti-depressant activity. It can be assumed that the long lasting effects might be due to its effects on kinases and transcription factors (Collins et al, 2008).…”

Caenorhabditis elegans Life Span Studies: The Challenge of Maintaining Synchronous Cohorts

“…[1][2][3][4][5] This increasing popularity is illustrated by the accelerating increase in the publication number of C. elegans life span studies. For instance, a keyword search of the PubMed database (National Center for Biotechnology Information, National Library of Medicine) determining the number of references containing the terms ''Caenorhabditis elegans'' and ''life span'' for each year between 1980 and 2009 reveals more than twice as many such publications in the 4 years between 2005 and 2009 than for the entire 25-year period before 2005.…”

“…Hence, this effect could lead to significant artefacts when biomarker studies are extended to higher ages. 1 Yong Loo Lin School of Medicine, Department of Biochemistry, Neurobiology and Ageing Programme and 2 Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore. …”